Intensive Care Treatment of Cardiogenic Shock and Post-cardiac Arrest Patients Registry

Conditions

R57.0 I46

Leonhard Pilsbacher, Angelina Krächan, Jonas Gmeiner, Clemens Walter von Musil, Mohamed Ali et al. (13 authors)

Heart & Lung2026-05-19

10.1016/j.hrtlng.2026.102847

Retrospective exploratory dual-center analysis of temporary transvenous cardiac pacing in cardiogenic shock

Clemens Walter von Musil, Valentina Riederer, Leonhard Pilsbacher, Christian Paulus, Severin Rudinger et al. (16 authors)

Scientific Reports2025-07-19

10.1038/s41598-025-10364-9

Comparison of balanced and unbalanced crystalloids as resuscitation fluid in patients treated for cardiogenic shock.

Gmeiner J, Bulach B, Lüsebrink E, Binzenhöfer L, Kupka D, Stocker T, Löw K, Weckbach L, Rudi WS, Petzold T, Kääb S, Hausleiter J, Hagl C, Massberg S, Orban M, Scherer C.

2023-09-062 citations

10.1186/s40560-023-00687-y

Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care

Clemens Scherer, Enzo Lüsebrink, Danny Kupka, Thomas J. Stocker, Konstantin Stark et al. (18 authors)

Journal of Clinical Medicine2020-11-2424 citations

10.3390/jcm9123803

Interventions

Group 1: Patients with cardiogenic shock or after cardiopulmonary resuscitation of any cause. This is an observatory study without any intervention.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with cardiogenic shock or after cardiopulmonary resuscitation of any cause with a minimum age of 18 years, who have been treated on the intensive care unit since the year 2012. Cardiogenic shock was defined by ESC guidelines, the IABP-SHOCK II trial and CULPRIT Shock trial as follows: hypotension despite adequate filling status (systolic blood pressure 90 mmHg) and signs of pulmonary congestion and at least one of the following clinical and laboratory signs of hypoperfusion: altered mental status, dizziness, cold, clammy skin and extremities, oliguria with urine output 2mmol/l, elevated creatinine, due to primary cardiac dysfunction.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Long-term survival after 1, 5 and 10 years.	—

Countries

Germany

Contacts

Public ContactClemens Scherer

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität München

Clemens.Scherer@med.uni-muenchen.de089 4400 72322

Outcome results

None listed